
CLMT Valuation
Calumet Inc
- Overview
- Forecast
- Valuation
- Earnings
CLMT Relative Valuation
CLMT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLMT is overvalued; if below, it's undervalued.
Historical Valuation
Calumet Inc (CLMT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.28 is considered Fairly compared with the five-year average of -5.49. The fair price of Calumet Inc (CLMT) is between 9.53 to 19.74 according to relative valuation methord.
Relative Value
Fair Zone
9.53-19.74
Current Price:13.60
Fair
-23.05
PE
1Y
3Y
5Y
Trailing
Forward
13.23
EV/EBITDA
Calumet Inc. (CLMT) has a current EV/EBITDA of 13.23. The 5-year average EV/EBITDA is 10.97. The thresholds are as follows: Strongly Undervalued below 4.93, Undervalued between 4.93 and 7.95, Fairly Valued between 13.99 and 7.95, Overvalued between 13.99 and 17.01, and Strongly Overvalued above 17.01. The current Forward EV/EBITDA of 13.23 falls within the Historic Trend Line -Fairly Valued range.
42.20
EV/EBIT
Calumet Inc. (CLMT) has a current EV/EBIT of 42.20. The 5-year average EV/EBIT is 13.96. The thresholds are as follows: Strongly Undervalued below -24.89, Undervalued between -24.89 and -5.47, Fairly Valued between 33.38 and -5.47, Overvalued between 33.38 and 52.80, and Strongly Overvalued above 52.80. The current Forward EV/EBIT of 42.20 falls within the Overvalued range.
0.28
PS
Calumet Inc. (CLMT) has a current PS of 0.28. The 5-year average PS is 0.31. The thresholds are as follows: Strongly Undervalued below 0.05, Undervalued between 0.05 and 0.18, Fairly Valued between 0.45 and 0.18, Overvalued between 0.45 and 0.58, and Strongly Overvalued above 0.58. The current Forward PS of 0.28 falls within the Historic Trend Line -Fairly Valued range.
-24.85
P/OCF
Calumet Inc. (CLMT) has a current P/OCF of -24.85. The 5-year average P/OCF is 11.82. The thresholds are as follows: Strongly Undervalued below -204.74, Undervalued between -204.74 and -96.46, Fairly Valued between 120.11 and -96.46, Overvalued between 120.11 and 228.39, and Strongly Overvalued above 228.39. The current Forward P/OCF of -24.85 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Calumet Inc. (CLMT) has a current P/FCF of 0.00. The 5-year average P/FCF is 4.12. The thresholds are as follows: Strongly Undervalued below -118.00, Undervalued between -118.00 and -56.94, Fairly Valued between 65.17 and -56.94, Overvalued between 65.17 and 126.23, and Strongly Overvalued above 126.23. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Calumet Inc (CLMT) has a current Price-to-Book (P/B) ratio of -1.17. Compared to its 3-year average P/B ratio of -2.40 , the current P/B ratio is approximately -51.37% higher. Relative to its 5-year average P/B ratio of -7.69, the current P/B ratio is about -84.83% higher. Calumet Inc (CLMT) has a Forward Free Cash Flow (FCF) yield of approximately -16.75%. Compared to its 3-year average FCF yield of -21.86%, the current FCF yield is approximately -23.38% lower. Relative to its 5-year average FCF yield of -13.94% , the current FCF yield is about 20.20% lower.
-1.17
P/B
Median3y
-2.40
Median5y
-7.69
-16.75
FCF Yield
Median3y
-21.86
Median5y
-13.94
Competitors Valuation Multiple
The average P/S ratio for CLMT's competitors is 0.23, providing a benchmark for relative valuation. Calumet Inc Corp (CLMT) exhibits a P/S ratio of 0.28, which is 20.65% above the industry average. Given its robust revenue growth of -9.45%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CLMT decreased by 24.70% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -3.45 to -14.41.
The secondary factor is the Revenue Growth, contributed -9.45%to the performance.
Overall, the performance of CLMT in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

CLDX
Celldex Therapeutics Inc
24.340
USD
-4.55%

DMLP
Dorchester Minerals LP
24.770
USD
+0.20%

TROX
Tronox Holdings PLC
3.970
USD
+10.89%

TVTX
Travere Therapeutics Inc
19.010
USD
+1.01%

CSTM
Constellium SE
14.300
USD
-0.97%

HE
Hawaiian Electric Industries Inc
11.355
USD
-0.39%

CUBI
Customers Bancorp Inc
65.780
USD
-0.15%

VET
Vermilion Energy Inc
7.170
USD
-0.42%

LTC
LTC Properties Inc
35.785
USD
+0.75%

MAG
MAG Silver Corp
22.795
USD
-1.15%
FAQ

Is Calumet Inc (CLMT) currently overvalued or undervalued?
Calumet Inc (CLMT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.28 is considered Fairly compared with the five-year average of -5.49. The fair price of Calumet Inc (CLMT) is between 9.53 to 19.74 according to relative valuation methord.

What is Calumet Inc (CLMT) fair value?

How does CLMT's valuation metrics compare to the industry average?

What is the current P/B ratio for Calumet Inc (CLMT) as of Aug 18 2025?

What is the current FCF Yield for Calumet Inc (CLMT) as of Aug 18 2025?

What is the current Forward P/E ratio for Calumet Inc (CLMT) as of Aug 18 2025?
